OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $815,393 Invested

2023

Imeka

Maxime Descoteaux, PhD

Diffusion MRI-based white matter measures as monitoring biomarkers for clinical trials in Alzheimer’s disease

  • Funding Amount: $815,393
  • Organization Type: Biotechnology/For Profit
  • Program: Biomarkers
  • Target: Neuroinflammation
  • Status: Active